AMGN vs ENTA · P/E 24, rev $10.05B vs rev $65.3M
Amgen Inc (AMGN) versus Enanta Pharmaceuticals Inc (ENTA) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Enanta Pharmaceuticals Inc (ENTA) is a biotechnology company listed on US.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported ENTA revenue for 2025-09-30 was $65.3M. Net income was -$81.9M. ENTA currently screens at market cap $328.0M.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. ENTA currently screens at market cap $328.0M.
Not investment advice. Open the AMGN and ENTA stock pages for the full models.
Not investment advice.